Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 18, 2012Therapeutic Drug Monitoring

Associations Between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 Alleles in Relation to Efavirenz and Nevirapine Pharmacokinetics in HIV-Infected Individuals

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSandra G. HeilNational Institute for Public Health and the EnvironmentPSPaul W. SchenkLeiden University Medical CenterIHIlse van der Heiden

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heil et al. (2012) studied this question.

synapsesocial.com/papers/6a8ab1f72796af338c679a99https://doi.org/10.1097/ftd.0b013e31824868f3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans2009 · 137 citations
  2. 2Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *262007 · 222 citations
  3. 3Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans2009 · 105 citations
  4. 4Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients2001 · 838 citations
  5. 5<i>CYP2B6</i> (c.516G→T) and <i>CYP2A6</i> (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV‐infected patients2009 · 116 citations